157 related articles for article (PubMed ID: 16427371)
1. Postnatal growth and bone mass in mice with IGF-I haploinsufficiency.
He J; Rosen CJ; Adams DJ; Kream BE
Bone; 2006 Jun; 38(6):826-35. PubMed ID: 16427371
[TBL] [Abstract][Full Text] [Related]
2. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
[TBL] [Abstract][Full Text] [Related]
3. Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weight.
Hamrick MW; Ding KH; Ponnala S; Ferrari SL; Isales CM
J Bone Miner Res; 2008 Jun; 23(6):870-8. PubMed ID: 18435579
[TBL] [Abstract][Full Text] [Related]
4. Effects of increased muscle mass on bone in male mice overexpressing IGF-I in skeletal muscles.
Banu J; Wang L; Kalu DN
Calcif Tissue Int; 2003 Aug; 73(2):196-201. PubMed ID: 14565602
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of human hydroxysteroid (17beta) dehydrogenase 2 induces disturbance in skeletal development in young male mice.
Shen Z; Peng Z; Sun Y; Väänänen HK; Poutanen M
J Bone Miner Res; 2008 Aug; 23(8):1217-26. PubMed ID: 18348690
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling.
Jiang J; Lichtler AC; Gronowicz GA; Adams DJ; Clark SH; Rosen CJ; Kream BE
Bone; 2006 Sep; 39(3):494-504. PubMed ID: 16644298
[TBL] [Abstract][Full Text] [Related]
7. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
Dubé PE; Forse CL; Bahrami J; Brubaker PL
Gastroenterology; 2006 Aug; 131(2):589-605. PubMed ID: 16890611
[TBL] [Abstract][Full Text] [Related]
8. Skeletal changes in transgenic male mice expressing human cytochrome p450 aromatase.
Peng Z; Li X; Mäkelä S; Väänänen HK; Poutanen M
J Bone Miner Res; 2004 Aug; 19(8):1320-8. PubMed ID: 15231020
[TBL] [Abstract][Full Text] [Related]
9. Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences.
Mohan S; Baylink DJ
J Endocrinol; 2005 Jun; 185(3):415-20. PubMed ID: 15930167
[TBL] [Abstract][Full Text] [Related]
10. Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor -/- mice.
Sjögren K; Bohlooly-Y M; Olsson B; Coschigano K; Törnell J; Mohan S; Isaksson OG; Baumann G; Kopchick J; Ohlsson C
Biochem Biophys Res Commun; 2000 Jan; 267(2):603-8. PubMed ID: 10631109
[TBL] [Abstract][Full Text] [Related]
11. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants.
Akcakus M; Koklu E; Kurtoglu S; Kula M; Koklu SS
Am J Perinatol; 2006 Nov; 23(8):473-80. PubMed ID: 17094045
[TBL] [Abstract][Full Text] [Related]
12. A general IGF-I overexpression effectively rescued somatic growth and bone deficiency in mice caused by growth hormone receptor knockout.
De Jesus K; Wang X; Liu JL
Growth Factors; 2009 Dec; 27(6):438-47. PubMed ID: 19824875
[TBL] [Abstract][Full Text] [Related]
13. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice.
Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM
J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent onset of liver-specific IGF-I gene deficiency and its persistence in old age: implications for postnatal growth and insulin resistance in LID mice.
Tang Z; Yu R; Lu Y; Parlow AF; Liu JL
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E288-95. PubMed ID: 15769793
[TBL] [Abstract][Full Text] [Related]
15. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice.
Windahl SH; Vidal O; Andersson G; Gustafsson JA; Ohlsson C
J Clin Invest; 1999 Oct; 104(7):895-901. PubMed ID: 10510330
[TBL] [Abstract][Full Text] [Related]
16. Loss of sex-specific difference in femoral bone parameters in male leptin knockout mice.
Wang X; Rundle CH; Wergedal JE; Srivastava AK; Mohan S; Lau KH
Calcif Tissue Int; 2007 Jun; 80(6):374-82. PubMed ID: 17516018
[TBL] [Abstract][Full Text] [Related]
17. Generation of a new congenic mouse strain to test the relationships among serum insulin-like growth factor I, bone mineral density, and skeletal morphology in vivo.
Bouxsein ML; Rosen CJ; Turner CH; Ackert CL; Shultz KL; Donahue LR; Churchill G; Adamo ML; Powell DR; Turner RT; Muller R; Beamer WG
J Bone Miner Res; 2002 Apr; 17(4):570-9. PubMed ID: 11918215
[TBL] [Abstract][Full Text] [Related]
18. Sexual dimorphism in cortical bone size and strength but not density is determined by independent and time-specific actions of sex steroids and IGF-1: evidence from pubertal mouse models.
Callewaert F; Venken K; Kopchick JJ; Torcasio A; van Lenthe GH; Boonen S; Vanderschueren D
J Bone Miner Res; 2010 Mar; 25(3):617-26. PubMed ID: 19888832
[TBL] [Abstract][Full Text] [Related]
19. Prenatal programming of skeletal development in the offspring: effects of maternal treatment with beta-hydroxy-beta-methylbutyrate (HMB) on femur properties in pigs at slaughter age.
Tatara MR; Sliwa E; Krupski W
Bone; 2007 Jun; 40(6):1615-22. PubMed ID: 17433802
[TBL] [Abstract][Full Text] [Related]
20. [Soy isoflavones with supplemental calcium provide protection against the loss of bone mass and influence insulin-like growth factor (IGF)-I after ovariectomy in rat].
Cheng MW; Liu JF; Yi GQ; Zhang XP; Zhu QH; Liu LG
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Sep; 40(5):328-31. PubMed ID: 17166423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
